Get Real Time Here
| Open0.225 | Close0.231 |
| Vol / Avg.314.835K / 244.490K | Mkt Cap4.057M |
| Day Range0.220 - 0.245 | 52 Wk Range0.190 - 2.650 |
Hillstream BioPharma Stock (NASDAQ:HILS), Quotes and News Summary
Hillstream BioPharma Stock (NASDAQ: HILS) stock price, news, charts, stock research, profile.
| Open0.225 | Close0.231 |
| Vol / Avg.314.835K / 244.490K | Mkt Cap4.057M |
| Day Range0.220 - 0.245 | 52 Wk Range0.190 - 2.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.160 | -0.160 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-17 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HILS | Hillstream BioPharma | 2.76% | 4.1M |
| DRMA | Dermata Therapeutics | -0.92% | 3.4M |
| PBLA | Panbela Therapeutics | -5.34% | 3.7M |
| BIOC | Biocept | -1.41% | 3.7M |
| SNPX | Synaptogenix | 30.17% | 3.7M |
How do I buy Hillstream BioPharma (HILS) stock?
You can purchase shares of Hillstream BioPharma (NASDAQ: HILS) through any online brokerage.
Who are Hillstream BioPharma's (HILS) competitors?
Other companies in Hillstream BioPharma’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).
What is the target price for Hillstream BioPharma (HILS) stock?
The latest price target for Hillstream BioPharma (NASDAQ: HILS) was reported by Dawson James on Monday, July 17, 2023. The analyst firm set a price target for 0.00 expecting HILS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Hillstream BioPharma (HILS)?
The stock price for Hillstream BioPharma (NASDAQ: HILS) is $0.2305 last updated September 22, 2023 at 7:59 PM UTC.
Does Hillstream BioPharma (HILS) pay a dividend?
There is no dividend information for Hillstream BioPharma.
When is Hillstream BioPharma (NASDAQ:HILS) reporting earnings?
Hillstream BioPharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Hillstream BioPharma (HILS) going to split?
There is no upcoming split for Hillstream BioPharma.
What sector and industry does Hillstream BioPharma (HILS) operate in?
Hillstream BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Hillstream BioPharma Stock (NASDAQ:HILS), Quotes and News Summary
Hillstream BioPharma Stock (NASDAQ: HILS) stock price, news, charts, stock research, profile.
| Open0.225 | Close0.231 |
| Vol / Avg.314.835K / 244.490K | Mkt Cap4.057M |
| Day Range0.220 - 0.245 | 52 Wk Range0.190 - 2.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.160 | -0.160 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-17 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HILS | Hillstream BioPharma | 2.76% | 4.1M |
| DRMA | Dermata Therapeutics | -0.92% | 3.4M |
| PBLA | Panbela Therapeutics | -5.34% | 3.7M |
| BIOC | Biocept | -1.41% | 3.7M |
| SNPX | Synaptogenix | 30.17% | 3.7M |
How do I buy Hillstream BioPharma (HILS) stock?
You can purchase shares of Hillstream BioPharma (NASDAQ: HILS) through any online brokerage.
Who are Hillstream BioPharma's (HILS) competitors?
Other companies in Hillstream BioPharma’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).
What is the target price for Hillstream BioPharma (HILS) stock?
The latest price target for Hillstream BioPharma (NASDAQ: HILS) was reported by Dawson James on Monday, July 17, 2023. The analyst firm set a price target for 0.00 expecting HILS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Hillstream BioPharma (HILS)?
The stock price for Hillstream BioPharma (NASDAQ: HILS) is $0.2305 last updated September 22, 2023 at 7:59 PM UTC.
Does Hillstream BioPharma (HILS) pay a dividend?
There is no dividend information for Hillstream BioPharma.
When is Hillstream BioPharma (NASDAQ:HILS) reporting earnings?
Hillstream BioPharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Hillstream BioPharma (HILS) going to split?
There is no upcoming split for Hillstream BioPharma.
What sector and industry does Hillstream BioPharma (HILS) operate in?
Hillstream BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Hillstream BioPharma Stock (NASDAQ:HILS), Quotes and News Summary
Hillstream BioPharma Stock (NASDAQ: HILS) stock price, news, charts, stock research, profile.
| Open0.225 | Close0.231 |
| Vol / Avg.314.835K / 244.490K | Mkt Cap4.057M |
| Day Range0.220 - 0.245 | 52 Wk Range0.190 - 2.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.160 | -0.160 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-17 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HILS | Hillstream BioPharma | 2.76% | 4.1M |
| DRMA | Dermata Therapeutics | -0.92% | 3.4M |
| PBLA | Panbela Therapeutics | -5.34% | 3.7M |
| BIOC | Biocept | -1.41% | 3.7M |
| SNPX | Synaptogenix | 30.17% | 3.7M |
How do I buy Hillstream BioPharma (HILS) stock?
You can purchase shares of Hillstream BioPharma (NASDAQ: HILS) through any online brokerage.
Who are Hillstream BioPharma's (HILS) competitors?
Other companies in Hillstream BioPharma’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).
What is the target price for Hillstream BioPharma (HILS) stock?
The latest price target for Hillstream BioPharma (NASDAQ: HILS) was reported by Dawson James on Monday, July 17, 2023. The analyst firm set a price target for 0.00 expecting HILS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Hillstream BioPharma (HILS)?
The stock price for Hillstream BioPharma (NASDAQ: HILS) is $0.2305 last updated September 22, 2023 at 7:59 PM UTC.
Does Hillstream BioPharma (HILS) pay a dividend?
There is no dividend information for Hillstream BioPharma.
When is Hillstream BioPharma (NASDAQ:HILS) reporting earnings?
Hillstream BioPharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Hillstream BioPharma (HILS) going to split?
There is no upcoming split for Hillstream BioPharma.
What sector and industry does Hillstream BioPharma (HILS) operate in?
Hillstream BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Hillstream BioPharma Stock (NASDAQ:HILS), Quotes and News Summary
Hillstream BioPharma Stock (NASDAQ: HILS) stock price, news, charts, stock research, profile.
| Open0.225 | Close0.231 |
| Vol / Avg.314.835K / 244.490K | Mkt Cap4.057M |
| Day Range0.220 - 0.245 | 52 Wk Range0.190 - 2.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.160 | -0.160 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-17 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HILS | Hillstream BioPharma | 2.76% | 4.1M |
| DRMA | Dermata Therapeutics | -0.92% | 3.4M |
| PBLA | Panbela Therapeutics | -5.34% | 3.7M |
| BIOC | Biocept | -1.41% | 3.7M |
| SNPX | Synaptogenix | 30.17% | 3.7M |
How do I buy Hillstream BioPharma (HILS) stock?
You can purchase shares of Hillstream BioPharma (NASDAQ: HILS) through any online brokerage.
Who are Hillstream BioPharma's (HILS) competitors?
Other companies in Hillstream BioPharma’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).
What is the target price for Hillstream BioPharma (HILS) stock?
The latest price target for Hillstream BioPharma (NASDAQ: HILS) was reported by Dawson James on Monday, July 17, 2023. The analyst firm set a price target for 0.00 expecting HILS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Hillstream BioPharma (HILS)?
The stock price for Hillstream BioPharma (NASDAQ: HILS) is $0.2305 last updated September 22, 2023 at 7:59 PM UTC.
Does Hillstream BioPharma (HILS) pay a dividend?
There is no dividend information for Hillstream BioPharma.
When is Hillstream BioPharma (NASDAQ:HILS) reporting earnings?
Hillstream BioPharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Hillstream BioPharma (HILS) going to split?
There is no upcoming split for Hillstream BioPharma.
What sector and industry does Hillstream BioPharma (HILS) operate in?
Hillstream BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Hillstream BioPharma Stock (NASDAQ:HILS), Quotes and News Summary
Hillstream BioPharma Stock (NASDAQ: HILS) stock price, news, charts, stock research, profile.
| Open0.225 | Close0.231 |
| Vol / Avg.314.835K / 244.490K | Mkt Cap4.057M |
| Day Range0.220 - 0.245 | 52 Wk Range0.190 - 2.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.160 | -0.160 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-17 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HILS | Hillstream BioPharma | 2.76% | 4.1M |
| DRMA | Dermata Therapeutics | -0.92% | 3.4M |
| PBLA | Panbela Therapeutics | -5.34% | 3.7M |
| BIOC | Biocept | -1.41% | 3.7M |
| SNPX | Synaptogenix | 30.17% | 3.7M |
How do I buy Hillstream BioPharma (HILS) stock?
You can purchase shares of Hillstream BioPharma (NASDAQ: HILS) through any online brokerage.
Who are Hillstream BioPharma's (HILS) competitors?
Other companies in Hillstream BioPharma’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).
What is the target price for Hillstream BioPharma (HILS) stock?
The latest price target for Hillstream BioPharma (NASDAQ: HILS) was reported by Dawson James on Monday, July 17, 2023. The analyst firm set a price target for 0.00 expecting HILS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Hillstream BioPharma (HILS)?
The stock price for Hillstream BioPharma (NASDAQ: HILS) is $0.2305 last updated September 22, 2023 at 7:59 PM UTC.
Does Hillstream BioPharma (HILS) pay a dividend?
There is no dividend information for Hillstream BioPharma.
When is Hillstream BioPharma (NASDAQ:HILS) reporting earnings?
Hillstream BioPharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Hillstream BioPharma (HILS) going to split?
There is no upcoming split for Hillstream BioPharma.
What sector and industry does Hillstream BioPharma (HILS) operate in?
Hillstream BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Hillstream BioPharma Stock (NASDAQ:HILS), Quotes and News Summary
Hillstream BioPharma Stock (NASDAQ: HILS) stock price, news, charts, stock research, profile.
| Open0.225 | Close0.231 |
| Vol / Avg.314.835K / 244.490K | Mkt Cap4.057M |
| Day Range0.220 - 0.245 | 52 Wk Range0.190 - 2.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.160 | -0.160 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-17 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HILS | Hillstream BioPharma | 2.76% | 4.1M |
| DRMA | Dermata Therapeutics | -0.92% | 3.4M |
| PBLA | Panbela Therapeutics | -5.34% | 3.7M |
| BIOC | Biocept | -1.41% | 3.7M |
| SNPX | Synaptogenix | 30.17% | 3.7M |
How do I buy Hillstream BioPharma (HILS) stock?
You can purchase shares of Hillstream BioPharma (NASDAQ: HILS) through any online brokerage.
Who are Hillstream BioPharma's (HILS) competitors?
Other companies in Hillstream BioPharma’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).
What is the target price for Hillstream BioPharma (HILS) stock?
The latest price target for Hillstream BioPharma (NASDAQ: HILS) was reported by Dawson James on Monday, July 17, 2023. The analyst firm set a price target for 0.00 expecting HILS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Hillstream BioPharma (HILS)?
The stock price for Hillstream BioPharma (NASDAQ: HILS) is $0.2305 last updated September 22, 2023 at 7:59 PM UTC.
Does Hillstream BioPharma (HILS) pay a dividend?
There is no dividend information for Hillstream BioPharma.
When is Hillstream BioPharma (NASDAQ:HILS) reporting earnings?
Hillstream BioPharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Hillstream BioPharma (HILS) going to split?
There is no upcoming split for Hillstream BioPharma.
What sector and industry does Hillstream BioPharma (HILS) operate in?
Hillstream BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Hillstream BioPharma Stock (NASDAQ:HILS), Quotes and News Summary
Hillstream BioPharma Stock (NASDAQ: HILS) stock price, news, charts, stock research, profile.
| Open0.225 | Close0.231 |
| Vol / Avg.314.835K / 244.490K | Mkt Cap4.057M |
| Day Range0.220 - 0.245 | 52 Wk Range0.190 - 2.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.160 | -0.160 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-17 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HILS | Hillstream BioPharma | 2.76% | 4.1M |
| DRMA | Dermata Therapeutics | -0.92% | 3.4M |
| PBLA | Panbela Therapeutics | -5.34% | 3.7M |
| BIOC | Biocept | -1.41% | 3.7M |
| SNPX | Synaptogenix | 30.17% | 3.7M |
How do I buy Hillstream BioPharma (HILS) stock?
You can purchase shares of Hillstream BioPharma (NASDAQ: HILS) through any online brokerage.
Who are Hillstream BioPharma's (HILS) competitors?
Other companies in Hillstream BioPharma’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).
What is the target price for Hillstream BioPharma (HILS) stock?
The latest price target for Hillstream BioPharma (NASDAQ: HILS) was reported by Dawson James on Monday, July 17, 2023. The analyst firm set a price target for 0.00 expecting HILS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Hillstream BioPharma (HILS)?
The stock price for Hillstream BioPharma (NASDAQ: HILS) is $0.2305 last updated September 22, 2023 at 7:59 PM UTC.
Does Hillstream BioPharma (HILS) pay a dividend?
There is no dividend information for Hillstream BioPharma.
When is Hillstream BioPharma (NASDAQ:HILS) reporting earnings?
Hillstream BioPharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Hillstream BioPharma (HILS) going to split?
There is no upcoming split for Hillstream BioPharma.
What sector and industry does Hillstream BioPharma (HILS) operate in?
Hillstream BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Hillstream BioPharma Stock (NASDAQ:HILS), Quotes and News Summary
Hillstream BioPharma Stock (NASDAQ: HILS) stock price, news, charts, stock research, profile.
| Open0.225 | Close0.231 |
| Vol / Avg.314.835K / 244.490K | Mkt Cap4.057M |
| Day Range0.220 - 0.245 | 52 Wk Range0.190 - 2.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.160 | -0.160 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-17 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HILS | Hillstream BioPharma | 2.76% | 4.1M |
| DRMA | Dermata Therapeutics | -0.92% | 3.4M |
| PBLA | Panbela Therapeutics | -5.34% | 3.7M |
| BIOC | Biocept | -1.41% | 3.7M |
| SNPX | Synaptogenix | 30.17% | 3.7M |
How do I buy Hillstream BioPharma (HILS) stock?
You can purchase shares of Hillstream BioPharma (NASDAQ: HILS) through any online brokerage.
Who are Hillstream BioPharma's (HILS) competitors?
Other companies in Hillstream BioPharma’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).
What is the target price for Hillstream BioPharma (HILS) stock?
The latest price target for Hillstream BioPharma (NASDAQ: HILS) was reported by Dawson James on Monday, July 17, 2023. The analyst firm set a price target for 0.00 expecting HILS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Hillstream BioPharma (HILS)?
The stock price for Hillstream BioPharma (NASDAQ: HILS) is $0.2305 last updated September 22, 2023 at 7:59 PM UTC.
Does Hillstream BioPharma (HILS) pay a dividend?
There is no dividend information for Hillstream BioPharma.
When is Hillstream BioPharma (NASDAQ:HILS) reporting earnings?
Hillstream BioPharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Hillstream BioPharma (HILS) going to split?
There is no upcoming split for Hillstream BioPharma.
What sector and industry does Hillstream BioPharma (HILS) operate in?
Hillstream BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Hillstream BioPharma Stock (NASDAQ:HILS), Quotes and News Summary
Hillstream BioPharma Stock (NASDAQ: HILS) stock price, news, charts, stock research, profile.
| Open0.225 | Close0.231 |
| Vol / Avg.314.835K / 244.490K | Mkt Cap4.057M |
| Day Range0.220 - 0.245 | 52 Wk Range0.190 - 2.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.160 | -0.160 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-17 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HILS | Hillstream BioPharma | 2.76% | 4.1M |
| DRMA | Dermata Therapeutics | -0.92% | 3.4M |
| PBLA | Panbela Therapeutics | -5.34% | 3.7M |
| BIOC | Biocept | -1.41% | 3.7M |
| SNPX | Synaptogenix | 30.17% | 3.7M |
How do I buy Hillstream BioPharma (HILS) stock?
You can purchase shares of Hillstream BioPharma (NASDAQ: HILS) through any online brokerage.
Who are Hillstream BioPharma's (HILS) competitors?
Other companies in Hillstream BioPharma’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).
What is the target price for Hillstream BioPharma (HILS) stock?
The latest price target for Hillstream BioPharma (NASDAQ: HILS) was reported by Dawson James on Monday, July 17, 2023. The analyst firm set a price target for 0.00 expecting HILS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Hillstream BioPharma (HILS)?
The stock price for Hillstream BioPharma (NASDAQ: HILS) is $0.2305 last updated September 22, 2023 at 7:59 PM UTC.
Does Hillstream BioPharma (HILS) pay a dividend?
There is no dividend information for Hillstream BioPharma.
When is Hillstream BioPharma (NASDAQ:HILS) reporting earnings?
Hillstream BioPharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Hillstream BioPharma (HILS) going to split?
There is no upcoming split for Hillstream BioPharma.
What sector and industry does Hillstream BioPharma (HILS) operate in?
Hillstream BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.